Sterile Injectable Drugs Market, By Type (Small Molecule and Large Molecule), By Therapeutic Application (Cancer, Diabetes, Cardiovascular Diseases, Infectious Disorders, Central Nervous Systems, Musculoskeletal, Anti-Viral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI384720 | Publish Date: March 2024 | No. of Pages: 176

Global Sterile Injectable Drugs Market Overview

Introduction:

Sterile injectable drugs market was valued at US$ 706.9 Billion in 2024 and is projected to grow at a CAGR of 4.70% to reach US$ 1077.1 Billion by 2034.

The Sterile Injectable Drugs molecule is known as active substances. They are divided into two class, large and small molecule as they differ in the manufacturing process, size, and mode of action in the body. Small molecules are mostly chemically manufactured active-substance molecules while large molecule, also known as biologics are therapeutic proteins. They are composed of more than 1,300 amino acids. Moreover, the large molecule is produced through genetically modified cells of microorganisms such as bacteria and yeast.

Drivers and Restraints:

Increasing in the prevalence of chronic diseases such as cardiovascular disease, diabetes is a major factor driving the growth of the global sterile injectable market globally. According to data published by the National Institute of Cancer, in 2016, about 1,685,210 new cancer cases are likely to be diagnosed in the U.S. and 5,95,690 patients will surrender to the disease. Also, growing investment in R&D by major pharmaceutical players for developing disease-specific drugs is projected to boost the growth of the global market over the forecast period. Furthermore, the rising number for drug approvals by the health authority for injectable and subsequently successful commercialization and launching of innovative drugs is anticipated to further propel the growth of the global market over the forecast period. However, manufacturing of sterile injectable involves the high cost of equipment, packaging, storage, and distribution which in turn hampers the growth of the target market. Nevertheless, various companies are focusing on developing innovative drugs that can absorb in the body quickly providing a quick therapeutic response, will create lucrative opportunities for major players in the global sterile injectable market over the forecast period.

Segmentation:

The  sterile injectable drugs market is segmented based on type, therapeutic application, distribution channel, and region.

Based on type, the global sterile injectable drugs market is segmented into small molecule and large molecule. Based on therapeutic application, the global market is segmented into cancer, diabetes, cardiovascular diseases, infectious disorders, central nervous systems, musculoskeletal, anti-viral, and others. Based on the distribution channel, the target market is classified into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies distribution channel segment is projected to dominate the market in the future, due to the major patient population in hospitals.

On the region, the global sterile injectable drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific is accounted to register the highest rate of growth in the sterile injectable drugs market. This is mainly attributed due to the presence of a large patient pool, rising awareness about sterile injectable drugs, presence of various small pharma companies in India and China, and the introduction of different types of policies by various government bodies. North America is estimated to lead the market for sterile injectable drugs over the forecast period, due to the presence of major players in the region, rapid developments made in healthcare infrastructure, and huge investments made in the research and development. The rise in the prevalence of chronic diseases, increase in investment witnessed across the healthcare sector, and the enforcement of strict government regulations for sterile injectable drugs, is likely to boost this market in the European region.

Key Players:

The key players operating the global sterile injectable drugs market involves AstraZeneca plc., Novartis AG, Baxter International Inc., Johnson & Johnson, Sanofi S.A., Pfizer Inc., GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Inc., and Nova Nordisk A/S. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the types to gain a competitive edge in the target market. For instance, on 6th January 2020, AstraZeneca announced the U.S Food and Drug Administration (FDA) has established a supplemental New Drug Application (sNDA) and granted Priority Review for Farxiga (dapagliflozin). To reduce the risk of cardiovascular (CV) death or the worsening of heart failure (HF) in adults with heart failure with reduced ejection fraction (HFrEF) with and without type-2 diabetes (T2D).

Detailed Segmentation:

Sterile Injectable Drugs Market, By Type:

  • Small Molecule
  • Large Molecule

Sterile Injectable Drugs Market, By Therapeutic Application:

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Infectious Disorders
  • Central Nervous Systems
  • Musculoskeletal
  • Anti-Viral
  • Others

Sterile Injectable Drugs Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Sterile Injectable Drugs Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa Sterile Injectable Drugs Market, By Type
      • Middle East & Africa Sterile Injectable Drugs Market, By Therapeutic Application
      • Middle East & Africa Sterile Injectable Drugs Market, By Distribution Channel
      • Middle East & Africa Sterile Injectable Drugs Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
      • Latin America Sterile Injectable Drugs Market, By Type
      • Latin America Sterile Injectable Drugs Market, By Therapeutic Application
      • Latin America Sterile Injectable Drugs Market, By Distribution Channel
      • Latin America Sterile Injectable Drugs Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Asia Pacific Sterile Injectable Drugs Market, By Type
      • Asia Pacific Sterile Injectable Drugs Market, By Therapeutic Application
      • Asia Pacific Sterile Injectable Drugs Market, By Distribution Channel
      • Asia Pacific Sterile Injectable Drugs Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific                                                                                                                                                                                     
    • Europe
      • Europe Sterile Injectable Drugs Market, By Type
      • Europe Sterile Injectable Drugs Market, By Therapeutic Application
      • Europe Sterile Injectable Drugs Market, By Distribution Channel
      • Europe Sterile Injectable Drugs Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • North America Sterile Injectable Drugs Market, By Type
    • North America Sterile Injectable Drugs Market, By Therapeutic Application
    • North America Sterile Injectable Drugs Market, By Distribution Channel
    • North America Sterile Injectable Drugs Market, By Country
      • U.S.
      • Canada

Company Profile:

  • AstraZeneca plc.
    • Company Overview
  • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Baxter International, Inc.
  • Novartis AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Pfizer, Inc.
  • GlaxoSmithKline plc.
  • Gilead Sciences, Inc.
  • Nova Nordisk A/S.

 “*” marked represents similar segmentation in other categories in the respective section

Global Sterile Injectable Drugs Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Sterile Injectable Drugs Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Therapeutic Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Sterile Injectable Drugs Market, By Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Small Molecule
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Large Molecule
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Sterile Injectable Drugs Market, By Therapeutic Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diabetes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Infectious Disorders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Central Nervous Systems
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Musculoskeletal
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Anti-Viral
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Sterile Injectable Drugs Market, By End-user, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Online Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Sterile Injectable Drugs Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • AstraZeneca plc *
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Baxter International, Inc.
      • Novartis AG
      • Johnson & Johnson
      • Merck & Co., Inc.
      • Sanofi S.A.
      • Pfizer, Inc.
      • GlaxoSmithKline plc.
      • Gilead Sciences, Inc.
      • Nova Nordisk A/S.
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The sterile injectable drugs market is segmented based on type, therapeutic application, distribution channel, and region.

the development of biologics and biosimilars, the increasing use of prefilled syringes and injectables, and advancements in drug delivery technologies, presenting significant opportunities in the global Sterile Injectable Drugs Market.

rising prevalence of chronic diseases, the growing demand for biopharmaceuticals, advancements in aseptic processing technologies, and the increasing need for parenteral drug administration in critical care settings.

North America and Europe are expected to dominate the Sterile Injectable Drugs Market, driven by a well-established pharmaceutical industry, high healthcare spending, and significant research and development activities in these regions.

The key players operating the global sterile injectable drugs market involves AstraZeneca plc., Novartis AG, Baxter International Inc., Johnson & Johnson, Sanofi S.A., Pfizer Inc., GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Inc., and Nova Nordisk A/S.